Ciloa is the first in the world to successfully transport adiponectin, a key hormone in metabolism, via extracellular vesicles. To put it simply, these vesicles are like little bio-packages sent from one cell to another. And when we master their contents, we can deliver exactly what the body needs, right where it's needed. This is where the project “Diadème” comes into play, a homegrown innovation that could shake up the treatment of metabolic diseases.
The biomedicine APN-sEV developed by Ciloa allows for the effective dissemination of this famous adiponectin throughout the body. This hormone, nicknamed “the guardian angel of metabolism,” plays a crucial role in regulating blood sugar, inflammation, and oxidative stress. In short, it's a bit like the Swiss Army knife of hormones, particularly useful for patients with type 2 diabetes or obesity.
A colossal therapeutic potential
According to Robert Mamoun, CEO of Ciloa, the initial results are mind-blowing: a real turning point for 2 billion patients worldwide. The action spectrum of adiponectin, enhanced by Ciloa's technology, goes well beyond diabetes. Cardiovascular diseases, retinopathies, skin conditions, and even certain hormonal cancers could also benefit from this advancement.
Ciloa, a spin-off from CNRS and the University of Montpellier, is establishing itself as a key player in the medicine of tomorrow. This is a remarkable feat of bioengineering made in Occitanie, proving that the greatest revolutions don’t always come from Silicon Valley, but sometimes emerge from a Montpellier lab.
See you in 2027 for the next steps
Clinical trials are scheduled for 2027, with a clear ambition: to change the game in treatment.Management of metabolic diseases. And even though there's still a long way to go, this announcement puts Montpellier on the global map of innovative biotech. A potential success story in the making, with colossal public health stakes.
One thing is for sure: Ciloa has discovered a scientific gem. What if tomorrow, treating diabetes came from tiny natural vesicles boosted by Montpellier's science? It's no longer a fantasy, it's a goal.
Source: Métropolitain